2024 BTEC conference (5/14/24 to 5/17/24)

ABSTRACT/SUMMARY Brain tumors (malignant and benign/non-malignant) affect approximately 25 persons per 100,000 people in the United States annually. It is estimated that there were 1,323,121 people living with a central nervous system tumor as of the end of 2019. The burden of these tumors is particularly large on children, adolescents and

young adults where brain tumors are among the top causes of cancer and sources of cancer death. With improvements in treatment for several types of brain tumors, the proportion of this population that are long term survivors is increasing. As a result, the experience and needs of survivors is increasingly relevant. The Brain

Tumor Epidemiology Consortium (BTEC) was initiated in 2003 to facilitate interactions among brain tumor epidemiologists and clinicians. Since that date, BTEC has offered yearly meetings for its participants and created working groups leading to the funding of several consortium projects. To help enhance participation

and increase accessibility of the conference to trainees and all participants, we offer a proposal to the NIH for partial funding of the 2024 BTEC conference in Mainz, Germany entitled, “Evolving Epidemiology of Brain Tumor Survivorship.” Our 2024 meeting will focus on brain tumor survivorship across the age spectrum, in

addition to our usual topics including improvements in predicting brain tumor risk and survival. The Mainz conference follows the tradition of alternating between a North American and a non-North American site each year.